ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janson, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janson, C
Eur Respir J 1991; 4: 544-550
Copyright © ERS Journals Ltd 1991


Original Articles

Plasma levels and effects of salbutamol after inhaled or i.v. administration in stable asthma

C Janson

The response and plasma levels of inhaled (0.15 mg.kg-1) and intravenous salbutamol (5 micrograms.kg-1) were studied in 12 patients who had previously been included in a study of acute severe asthma and were now in a stable phase. The maximal value for change (delta) in plasma salbutamol compared with the pretreatment value was higher after i.v. than after inhalation treatment (59 vs 30 nmol.l-1) but the areas under the curve (AUC) during 90 mins after treatment were similar for the two administration routes. The inter-individual differences in peak plasma salbutamol and AUC for delta plasma salbutamol were much greater after inhalation than after i.v. infusion. Immediately after treatment there was a greater increase in pulse rate (mean +17 vs +6 beats.min) and lower serum potassium level (mean -0.3 mmol.l-1) after i.v. than after inhalation treatment. The increase in peak expiratory flow (PEF) measured 90 min after the start of treatment (85 vs 31 l.min-1) and as AUC was significantly higher after inhalation than after i.v. treatment. Six patients had received i.v. treatment in the acute asthma study: in these patients delta PEF immediately after i.v. treatment was significantly lower in the stable situation (+49 vs +115 l.min-1). There was also a significant difference in the effect on the pulse rate immediately after i.v. treatment, with a decrease in the acute asthma and an increase in the stable asthma situation (-5 vs +16 beats.min-1).


This article has been cited by other articles:


Home page
ChestHome page
E. M. Kallergis, E. G. Manios, E. M. Kanoupakis, S. E. Schiza, H. E. Mavrakis, N. K. Klapsinos, and P. E. Vardas
Acute Electrophysiologic Effects of Inhaled Salbutamol in Humans
Chest, June 1, 2005; 127(6): 2057 - 2063.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. DHAND, M. GOODE, R. REID, J. B. FINK, P. J. FAHEY, and M. J. TOBIN
Preferential Pulmonary Retention of (S)-Albuterol after Inhalation of Racemic Albuterol
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1136 - 1141.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the European Respiratory Society.